Cytomegalovirus gB genotype distribution differs in human immunodeficiency virus-infected patients and immunocompromised allograft recipients

Journal of Infectious Diseases

Volumn 175, Issue 1, 1997, Pages 179-184

  Rasmussen, Lucy ^a   Hong, Christina ^b   Zipeto, Donate ^b   Morris, Shannon ^b   Sherman, Daniel ^b   Chou, Sunwen ^b   Miner, Richard ^b   Drew, W Lawrence ^b   Wolitz, Richard ^b   Dowling, Anna ^b   Warlord, Ann ^b   Merigan, Thomas C ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGRAFT; ARTICLE; CLINICAL ARTICLE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; PRIORITY JOURNAL;

EID: 16944366760     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/175.1.179     Document Type: Article

References (15)

1. Waner J, Weller T. Analysis of antigenic diversity among human cytomegalovirus by kinetic neutralization tests with high-titered rabbit antisera. Infect Immun 1978; 21:151-7.
2. Brown JM, Kaneshima H, Mocarski ES. Dramatic interstrain differences in the replication of human cytomegalovirus in SCID-hu mice. J Infect Dis 1995; 171:1599-603.
3. Rasmussen L, Mullenax J, Nelson R, Merigan T. Viral polypeptides detected by a complement-dependent neutralizing murine monoclonal antibody to human cytomegalovirus. J Virol 1985; 55:274-80.
4. Rasmussen LE, Nelson RM, Kelsall D, Merigan TC. Murine monoclonal antibody to a single protein neutralizes the infectivity of human cytomegalovirus. Proc Natl Acad Sci USA 1984; 81:876-80.
5. Navarro D, Paz P, Tugizov Z, Topp K, LaVail J, Pereira L. Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell, and fusion of infected cells. Virology 1993; 197:143-58.
6. Rasmussen L, Resta S, Merigan T. Human cytomegalovirus glycoprotein-receptor interactions. Transplant Proc 1991; 23:60-3.
7. Chou SW, Dennison KM. Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes. J Infect Dis 1991; 163:1229-34.
8. Chou S. Comparative analysis of sequence variation in gp116 and gp55 components of glycoprotein B of human cytomegalovirus. Virology 1992; 188:388-90.
9. Fries BC, Chou S, Boeckh M, Torok-Storb B. Frequency distribution of cytomegalovirus envelope glycoprotein genotypes in bone marrow transplant recipients. J Infect Dis 1994; 169:769-74.
10. Shepp D, Match M, Ashraf A, Lipson S, Millan C, Pergolizzi R. Cytomegalovirus glycoprotein B groups associated with retinitis in AIDS. J Infect Dis 1996; 174:184-7.
11. + cells in semen from human immunodeficiency virus-infected patients. J Infect Dis 1995; 171:432-6.
12. Rasmussen L, Morris S, Zipeto D, et al. Quantitation of human cytomegalovirus DNA from peripheral blood cells of human immunodeficiency virus-infected patients could predict cytomegalovirus retinitis. J Infect Dis 1995; 171:177-82.
13. Zipeto D, Morris S, Hong C, et al. Human cytomegalovirus (CMV) DNA in plasma reflects quantity of CMV DNA present in leukocytes. J Clin Microbiol 1995; 33:2607-11.
14. Zablotney S, Wentworth B, Alexander E. Antigenic relatedness of 17 strains of human cytomegalovirus. Am J Epidemiol 1978; 107:33643.
15. Rasmussen L, Morris S, Wolitz R, et al. Deficiency in antibody response to human cytomegalovirus glycoprotein gH in human immunodeficiency virus-infected patients at risk for cytomegalovirus retinitis. J Infect Dis 1994; 170:673-7.